Wendy M Van der Deure
Overview
Explore the profile of Wendy M Van der Deure including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baltussen J, Mooijaart S, Vulink A, Houtsma D, Van der Deure W, Westerman E, et al.
Breast Cancer Res Treat
. 2024 Apr;
206(2):337-346.
PMID: 38627318
Purpose: Palbociclib has become the standard of care for estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer, but real-world evidence in older women remains...
2.
Haine A, Notenboom C, Tan L, Ruiter R, Van der Deure W
Pharmacol Res Perspect
. 2022 Jul;
10(4):e00985.
PMID: 35811355
Paclitaxel is a commonly used chemotherapeutic agent. To minimize the risk of hypersensitivity reactions (HSRs), which occur in approximately 16-42% of patients, premedication with dexamethasone, clemastine, and ranitidine was standard...
3.
van Doorn L, van Rosmalen M, Van der Deure W, Oomen-de Hoop E, Porrazzo R, Wijngaard S, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359815
Chemotherapy-induced alopecia (CIA), a side effect with high impact, can be prevented by cooling the scalp during the administration of some cytotoxic drugs. However, the effects of this prolonged scalp...
4.
Belderbos B, Bins S, van Leeuwen R, Oomen-de Hoop E, van der Meer N, de Bruijn P, et al.
Clin Cancer Res
. 2017 Nov;
24(3):541-546.
PMID: 29150561
In ongoing clinical research on metastatic castration-resistant prostate cancer (mCRPC) treatment, the potential enhanced efficacy of the combination of taxanes with AR-targeted agents, that is, enzalutamide and abiraterone, is currently...
5.
Van der Deure W, Lugtenburg E, Dwarkasing R, Biermann K, Tjwa E
J Gastrointestin Liver Dis
. 2015 Mar;
24(1):7.
PMID: 25822424
No abstract available.
6.
Medici M, Rivadeneira F, Van der Deure W, Hofman A, van Meurs J, Styrkarsdottir U, et al.
Thyroid
. 2012 Jan;
22(2):223-4.
PMID: 22224817
No abstract available.
7.
A large-scale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels
Medici M, Van der Deure W, Verbiest M, Vermeulen S, Hansen P, Kiemeney L, et al.
Eur J Endocrinol
. 2011 Mar;
164(5):781-8.
PMID: 21367965
Objective: Minor variation in serum thyroid hormone (TH) levels can have important effects on various clinical endpoints. Although 45-65% of the inter-individual variation in serum TH levels is due to...
8.
Heemstra K, Hoftijzer H, Van der Deure W, Peeters R, Hamdy N, Pereira A, et al.
J Bone Miner Res
. 2010 Mar;
25(6):1385-91.
PMID: 20200941
The role of type 2 deiodinase (D2) in the human skeleton remains unclear. The D2 polymorphism Thr92Ala has been associated with lower enzymatic activity, which could result in lower local...
9.
Van der Deure W, Peeters R, Visser T
J Mol Endocrinol
. 2009 Jun;
44(1):1-11.
PMID: 19541799
Thyroid hormone is a pleiotropic hormone with widespread biological actions. For instance, adequate levels of thyroid hormone are critical for the development of different tissues such as the central nervous...
10.
Van der Deure W, Peeters R, Uitterlinden A, Hofman A, Breteler M, Witteman J, et al.
Clin Endocrinol (Oxf)
. 2009 Jan;
71(1):137-44.
PMID: 19178511
Introduction: Thyroid function and genetic variation in the hypothalamus-pituitary-thyroid axis have been implicated in blood pressure regulation and susceptibility to hypertension. However studies conducted thus far were small with controversial...